ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2023; 13(5): 162-170


Phytochemical analysis, antiproliferative and apoptosis-inducing properties of Persicaria strigosa Nakai

Ananta Swargiary, Mritunjoy Kumar Roy, Harmonjit Boro, Akalesh Kumar Verma, Manita Daimari, Jayanta Kumar Das.




Abstract
Cited by 0 Articles

Persicaria strigosa is an important medicinal plant having several ethnomedicinal values. This study investigated the phytochemical contents, antiproliferative, and apoptosis-inducing properties of P. strigosa. The phytocompounds were identified by the Gas Chromatography-Mass Spectrometry (GC-MS) technique. Antiproliferative and apoptosis-inducing properties were conducted in Dalton’s lymphoma cells. In-silico molecular docking, drug-likeness, absorption, distribution, metabolism, excretion, and toxicity (ADMET) were carried out to study the binding affinity and drug-likeness of the compounds. The study revealed a dose-dependent antiproliferative activity of the plant. GC-MS study identified 12 compounds from the ethyl acetate extract. Phytompounds C2, C5, C6, C7, and C12 showed the best binding affinity with the anti-apoptotic proteins. The phytocompounds were predicted to possess drug-likeness properties and a good ADMET profile. The findings suggest that P. strigosa could be a potential source of anticancer agents.

Key words: Persicaria strigosa, antiproliferative, anti-apoptosis, GC-MS, docking, drug-likeness, ADMET






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.